Publications by authors named "Hong I Wan"

Claim this Profile
E
Evorpacept plus rituximab for the treatment of relapsed or refractory non-Hodgkin lymphoma: results from the phase I ASPEN-01 study.
Tae Min Kim, Nehal J Lakhani, Jacob Soumerai, Manali Kamdar, Justin F Gainor, Hong I Wan

Haematologica· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study.
Nehal J Lakhani, Laura Q M Chow, Justin F Gainor, Patricia LoRusso, Keun-Wook Lee, Hong I Wan

Lancet Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity.
Tracy C Kuo, Amy Chen, Ons Harrabi, Jonathan T Sockolosky, Anli Zhang, Hong I Wan

J Hematol Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing and mitigating the interference of ALX148, a novel CD47 blocking agent, in pretransfusion compatibility testing.
Tae Yeul Kim, Mi Sook Yoon, Hein Hustinx, Janet Sim, Hong I Wan

Transfusion· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile.
Steven E Kauder, Tracy C Kuo, Ons Harrabi, Amy Chen, Emma Sangalang, Hong I Wan

PLoS One· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The characteristics of physical activity and gait in patients receiving radiotherapy in cancer induced bone pain.
Tonje A Sande, Angela C Scott, Barry J A Laird, Hong I Wan, Susan M Fleetwood-Walker

Radiother Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medial temporal lobe function during emotional memory in early Alzheimer's disease, mild cognitive impairment and healthy ageing: an fMRI study.
Mario A Parra, Vivek Pattan, Dichelle Wong, Anna Beaglehole, Jane Lonie, Hong I Wan

BMC Psychiatry· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease.
Holly D Soares, William Z Potter, Eve Pickering, Max Kuhn, Frederick W Immermann, Hong I Wan

Arch Neurol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of cerebrospinal fluid biomarkers in clinical trials for schizophrenia and depression.
Hong I Wan, Holly Soares, Jeffrey F Waring

Biomark Med· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations.
John M Ringman, Howard Schulman, Chris Becker, Ted Jones, Yuchen Bai, Hong I Wan

Arch Neurol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional imaging of emotional memory in bipolar disorder and schizophrenia.
Heather C Whalley, James McKirdy, Liana Romaniuk, Jessika Sussmann, Eve C Johnstone, Hong I Wan

Bipolar Disord· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
Robert L Martone, Hua Zhou, Kevin Atchison, Thomas Comery, Jane Z Xu, Hong I Wan

J Pharmacol Exp Ther· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational medicine lessons from flurizan's failure in Alzheimer's disease (AD) trial: Implication for future drug discovery and development for AD.
Hong I Wan, J Steve Jacobsen, J Lynn Rutkowski, Giora Z Feuerstein

Clin Transl Sci· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive endpoints as disease biomarkers: optimizing the congruency of preclinical models to the clinic.
Mark Day, Fuat Balci, Hong I Wan, Gerard B Fox, J Lynn Rutkowski

Curr Opin Investig Drugs· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis